We are live on ! Find out more
SWTX

SpringWorks Therapeutics
SWTX

Delisted

SWTX was delisted on the 30th of June, 2025.

Back to rankings

44 hedge funds and large institutions have $681M invested in SpringWorks Therapeutics in 2019 Q3 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

72.34% more ownership

Funds ownership: 0% → 72.34% (+72%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.96%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.11%
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$175M
2
BCLSI
Bain Capital Life Sciences Investors
Massachusetts
+$172M
3
PA
Perceptive Advisors
New York
+$76.1M
4
BI
BVF Inc
California
+$67.2M
5
BC
Boxer Capital
California
+$49.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$161M +$175M +7,406,307 New
BCLSI
2
Bain Capital Life Sciences Investors
Massachusetts
$158M +$172M +7,281,307 New
PA
3
Perceptive Advisors
New York
$69.8M +$76.1M +3,217,522 New
BI
4
BVF Inc
California
$61.7M +$67.2M +2,844,145 New
BC
5
Boxer Capital
California
$45M +$49.1M +2,075,905 New
Citadel Advisors
6
Citadel Advisors
Florida
$28.7M +$31.3M +1,323,817 New
Fidelity Investments
7
Fidelity Investments
Massachusetts
$24.1M +$26.3M +1,111,112 New
DM
8
Deerfield Management
New York
$22.8M +$24.8M +1,050,888 New
SB
9
Samsara BioCapital
California
$14.7M +$16M +676,602 New
ACH
10
ArrowMark Colorado Holdings
Colorado
$8.89M +$9.69M +409,892 New
Millennium Management
11
Millennium Management
New York
$8.75M +$9.54M +403,613 New
DCM
12
Driehaus Capital Management
Illinois
$7.88M +$8.59M +363,260 New
Massachusetts Financial Services
13
Massachusetts Financial Services
Massachusetts
$7.84M +$8.55M +361,772 New
SFM
14
Sphera Funds Management
Israel
$6.72M +$7.33M +310,000 New
AG
15
Artal Group
Luxembourg
$6.69M +$7.29M +308,526 New
LCM
16
Laurion Capital Management
New York
$6.68M +$7.28M +307,980 New
Jennison Associates
17
Jennison Associates
New York
$5.42M +$5.91M +250,201 New
Carson Wealth (CWM LLC)
18
Carson Wealth (CWM LLC)
Nebraska
$4.45M +$1.28M +53,948 New
Franklin Resources
19
Franklin Resources
California
$4.34M +$4.73M +200,000 New
Norges Bank
20
Norges Bank
Norway
$4.34M +$4.73M +200,000 New
Victory Capital Management
21
Victory Capital Management
Texas
$3.79M +$4.14M +175,000 New
OAM
22
Oxford Asset Management
United Kingdom
$3.65M +$3.98M +168,390 New
Ameriprise
23
Ameriprise
Minnesota
$3.59M +$3.92M +165,862 New
BlackRock
24
BlackRock
New York
$2.25M +$2.45M +103,579 New
MIM
25
Monashee Investment Management
Massachusetts
$1.79M +$1.96M +82,803 New
1
2

SWTX Hedge Fund Activity: Q3 2019 in Review

44 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q3 2019, worth a combined $681M.

Buyers outnumbered sellers: 44 funds opened new SWTX positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $175M.

  • 44 institutional investors held SpringWorks Therapeutics (SWTX) as of Q3 2019, up from 0 in Q2 2019.
  • Funds reported $681M of SpringWorks Therapeutics stock for Q3 2019.
  • 44 funds opened new SpringWorks Therapeutics positions in Q3 2019 and 0 closed out, a net change of +44 holders.
  • The largest SpringWorks Therapeutics buyer in Q3 2019 was OrbiMed, an estimated $175M added.

Based on aggregated 13F filings for Q3 2019.